myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome

Molecular and Cellular Biology

Volumn 18, Issue 10, 1998, Pages 5961-5969

  Flinn, Elizabeth M ^a   Busch, C Magnus C ^a   Wright, Anthony P H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEASOME;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; TUMOR;

MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 3543060464     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.10.5961     Document Type: Article

References (77)

1. Albert, T., B. Urlbauer, F. Kohlhuber, B. Hammersen, and D. Eick. 1994. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. Oncogene 9:759-763.
2. Alexandrova, N., J. Niklinski, V. Bliskovsky, G. A. Otterson, M. Blake, F. J. Kaye, and M. Zajac-Kaye. 1995. The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. Mol. Cell. Biol. 15:5188-5195.
3. Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359:423-426.
4. Amin, C., A. J. Wagner, and N. Hay. 1993. Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol. 13:383-390.
5. Ariga, H., Y. Imamura, and S. M. Iguchi-Ariga. 1989. DNA replication origin and transcriptional enhancer in c-myc gene share the c-myc protein binding sequences. EMBO J. 8:4273-4279.
6. Asker, C. E., K. P. Magnusson, S. P. Piccoli, K. Andersson, G. Klein, M. D. Cole, and K. G. Wiman. 1995. Mouse and rat B-myc share amino acid sequence homology with the c-myc transcriptional activator domain and contain a B-myc specific carboxy terminal region. Oncogene 11:1963-1969.
7. Bachmair, A., D. Finley, and A. Varshavsky. 1986. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234:179-186.
8. Beijersbergen, R. L., E. M. Hijmans, L. Zhu, and R. Bernards. 1994. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 13:4080-4086.
9. Benvenisty, N., A. Leder, A. Kuo, and P. Leder. 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev. 6:2513-2523.
10. Bhatia, K., K. Huppi, G. Spangler, D. Siwarski, R. lyer, and I. Magrath. 1993. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet. 5:56-61.
11. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
12. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
13. Bogyo, M., J. S. McMaster, M. Gaczynska, D. Tortorella, A. L. Goldberg, and H. Ploegh. 1997. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog Hslv by a new class of inhibitors. Proc. Natl. Acad. Sci. USA 94:6629-6634.
14. Bonvini, P., P. Nguyen, J. Trepel, and L. Neckers. 1998. In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome. Oncogene 16:1131-1140.
15. Brough, D. E., T. J. Hofmann, K. B. Ellwood, R. A. Townley, and M. D. Cole. 1995. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation. Mol. Cell. Biol. 15:1536-1544.
16. Christy, R. J., K. H. Kaestner, D. E. Geiman, and M. D. Lane. 1991. CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. USA 88:2593-2597.
17. Church, G. M., and W. Gilbert, 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991-1995.
18. Ciechanover, A., J. A. DiGiuseppe, B. Bercovich, A. Orian, J. D. Richter, A. L. Schwartz, and G. M. Brodeur. 1991. Degradation of nuclear oncoproteinsby the ubiquitin system in vitro. Proc. Natl. Acad. Sci. USA 88:139-143.
19. Crouch, D. H., F. Fisher, W. Clark, P. S. Jayaraman, C. R. Goding, and D. A. Gillespie. 1993. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity. Oncogene 8:1849-1855.
20. Dang, C. V., M. McGuire, M. Buckmire, and W. M. Lee. 1989. Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein. Nature 337:664-666.
21. Dang, C. V., H. van Dam, M. Buckmire, and W. M. Lee. 1989. DNA-binding domain of human c-Myc produced in Escherichia coli. Mol. Cell. Biol. 9:2477-2486.
22. Eilers, M., S. Schirm, and J. M. Bishop. 1991. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10:133-141.
23. Flinn, E. M. Unpublished data.
24. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517.
25. Glotzer, M., A. W. Murray, and M. W. Kirschner. 1991. Cyclin is degraded by the ubiquitin pathway. Nature 349:132-138.
26. Gorski, K., M. Carneiro, and U. Schibier. 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767-776.
27. Grandori, C., J. Mac, F. Sichelt, D. E. Ayer, and R. N. Eisenman. 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15:4344-4357.
28. Gu, W., K. Bhatia, I. T. Magrath, C. V. Dang, and R. Dalla-Favera. 1994. Binding and suppression of the Myc transcriptional activation domain by p107. Science 264:251-254.
29. Gupta, S., A. Seth, and R. J. Davis. 1993. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc. Natl. Acad. Sci. USA 90:3216-3220.
30. Hann, S. R., and R. N. Eisenman. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:2486-2497.
31. Hann, S. R., M. W. King, D. L. Bentley, C. W. Anderson, and R. N. Eisenman. 1988. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell 52:185-195.
32. Hateboer, G., H. T. Timmers, A. K. Rustgi, M. Billaud, L. J. van't Veer, and R. Bernards. 1993. TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. Proc. Natl. Acad. Sci. USA 90:8489-8493.
33. Henriksson, M., A. Bakardjiev, G. Klein, and B. Luscher. 1993. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. Oncogene 8:3199-3209.
34. Hochstrasser, M., and A. Varshavsky. 1990. In vivo degradation of a transcriptional regulator: the yeast alpha 2 represser. Cell 61:697-708.
35. Horvath, A., and H. Riezman. 1994. Rapid protein extraction from Saccharomyces cerevisiae. Yeast 10:1305-1310.
36. Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168.
37. Jones, E. W. 1991. Three proteolytic systems in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 266:7963-7966.
38. Jones, R. M., J. Branda, K. A. Johnston, M. Polymenis, M. Gadd, A. Rustgi, L. Callanan, and E. V. Schmidt. 1996. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol. Cell. Biol. 16:4754-4764.
39. Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An aminoterminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:5914-5920.
40. Kohl, N. E., E. Legouy, R. A. DePinho, P. D. Nisen, R. K. Smith, C. E. Gee, and F. W. Alt. 1986. Human N-myc is closely related in organization and nucleotide sequence to c-myc. Nature 319:73-77.
41. Kornitzer, D., B. Raboy, R. G. Kulka, and G. R. Fink. 1994. Regulated degradation of the transcription factor Gcn4. EMBO J. 13:6021-6030.
42. Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367-382.
43. Laird-Offringa, I. A. 1992. What determines the instability of c-myc protooncogene mRNA? Bioessays 14:119-124.
44. Lech, K., K. Anderson, and R. Brent. 1988. DNA-bound Fos proteins activate transcription in yeast. Cell 52:179-184.
45. Legouy, E., R. DePinho, K. Zimmerman, R. Collum, G. Yancopoulos, L. Mitsock, R. Kriz, and F. W. Alt. 1987. Structure and expression of the murine L-myc gene. EMBO J. 6:3359-3366.
46. Lewis, B. C., H. Shim, Q. Li, C. S. Wu, L. A. Lee, A. Maity, and C. V. Dang. 1997. Identification of putative c-myc-responsive genes: characterization of rcl, a novel growth-related gene. Mol. Cell. Biol. 17:4967-4978.
47. Li, L. H., C. Nerlov, G. Prendergast, D. MacGregor, and E. B. Ziff. 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13:4070-4079.
48. Luscher, B., and R. N. Eisenman. 1988. c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol. Cell, Biol. 8:2504-2512.
49. Luscher, B., and R. N. Eisenman. 1990. New light on Myc and Myb. I. Myc. Genes Dev. 4:2025-2035.
50. Magrath, I. 1990. The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 55:133-270.
51. Marhin, W. W., S. Chen, L. M. Facchini, A. J. Fornace, Jr., and L. Z. Penn. 1997. Myc represses the growth arrest gene gadd45. Oncogene 14:2825-2834.
52. McEwan, I. J., K. Dahlman-Wright, J. Ford, and A. P. Wright. 1996. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding. Biochemistry 35:9584-9593.
53. Murakami, Y., S. Matsufuji, T. Kameji, S. Hayashi, K. Igarashi, T. Tamura, K. Tanaka, and A. Ichihara. 1992. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360:597-599.
54. Penn, L. J. Z., M. W. Brooks, E. M. Laufer, T. D. Littlewood, J. P. Morgenstern, G. I. Evan, W. M. F. Lee, and H. Land. 1990. Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol. Cell. Biol. 10:4961-4966.
55. Philipp, A., A. Schneider, I. Vasrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and M. Eilers. 1994. Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol. 14:4032-4043.
56. Pickart, C. M. 1997. Targeting of substrates to the 268 proteasome. FASEB J. 11:1055-1066.
57. Pistoi, S., J. Roland, C. Babinet, and D. Morello. 1996. Exon 2-mediated c-myc mRNA decay in vivo is independent of its translation. Mol. Cell. Biol. 16:5107-5116.
58. Prendergast, G. C., L. E. Diamond, D. Dahl, and M. D. Cole. 1990. The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1. Mol. Cell. Biol. 10:1265-1269.
59. Prendergast, G. C., and E. B. Ziff. 1992. A new bind for Myc. Trends Genet. 8:91-96.
60. Pulverer, B. J., C. Fisher, K. Vousden, T. Littlewood, G. Evan, and J. R. Woodgett. 1994. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9:59-70.
61. Ramsay, G., G. I. Evan, and J. M. Bishop. 1984. The protein encoded by the human proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA 81:7742-7746.
62. Rechsteiner, M., and S. W. Rogers. 1996. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21:267-271.
63. Rose, M. D., F. Winston, and P. Heiter. 1990. Yeast genetics: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
64. Rosenberg-Hasson, Y., Z. Bercovich, A. Ciechanover, and C. Kahana. 1989. Degradation of ornithine decarboxylase in mammalian cells is ATP dependent but ubiquitin independent. Eur. J. Biochem. 185:469-474.
65. Sand, J., T. D. Halazonetis, W. Murphy, and P. Leder. 1987. Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity. Proc. Natl. Acad. Sci. USA 84:170-173.
66. Schiavi, S. C., J. G. Belasco, and M. E. Greenberg. 1992. Regulation of proto-oncogene mRNA stability. Biochim. Biophys. Acta 1114:95-106.
67. Schmitt, M. E., T. A. Brown, and B. L. Trumpower. 1990. A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucleic Acids Res. 18:3091-3092.
68. Spotts, G. D., S. V. Patel, Q. Xiao, and S. R. Kann. 1997. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol. Cell. Biol. 17:1459-1468.
69. Stanton, L. W., M. Schwab, and J. M. Bishop. 1986. Nucleotide sequence of the human N-myc gene. Proc. Natl. Acad. Sci. USA 83:1772-1776.
70. Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697-1709.
71. Sugiyama, A., A. Kume, K. Nemoto, S. Y. Lee, Y. Asami, F. Nemoto, S. Nishimura, and Y. Kuchino. 1989. Isolation and characterization of s-myc, a member of the rat myc gene family. Proc. Natl. Acad. Sci. USA 86:9144-9148.
72. Svaren, J., J. Schmitz, and W. Horz. 1994. The transactivation domain of Pho4 is required for nucleosome disruption at the PHO5 promoter. EMBO J. 13:4856-4862.
73. Treier, M., L. M. Staszewski, and D. Bohmann. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78:787-798.
74. Visintin, R., S. Prinz, and A. Amon. 1997. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 278:460-463.
75. Wagner, A. J., C. Meyers, L. A. Laimins, and N. Hay. 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:879-883.
76. Yeilding, N. M., and W. M. Lee. 1997. Coding elements in exons 2 and 3 target c-myc mRNA downregulation during myogenic differentiation. Mol. Cell. Biol. 17:2698-2707.
77. Yeilding, N. M., M. T. Kehman, and W. M. Lee. 1996. Identification of sequences in c-myc mRNA that regulate its steady-state levels. Mol. Cell. Biol. 16:3511-3522.